Its important that you carefully read the instructions and do not include any note in the e-transfer such as product names, order number, or anything relating to steroids
Phase 2 trial data have explored weekly subcutaneous doses ranging from 1 mg to 12 mg, administered via a gradual escalation schedule
| 1 Youre not in a calorie deficit | 2 Youre in a weight-loss plateau | 3 Your current dose isnt high enough to promote lower hunger | Practical strategies | Frequently asked questions | Take home message The main reasons youre not losing weight on semaglutide (Wegovy/Ozempic) might be that youre not eating in a calorie deficit, youve hit a weight-loss plateau, or the current dose that youre on isnt high enough to lower your hunger to the point where youre eating less
When considering which GLP-1 medication is best for you, the cost is a significant factor to explore
Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed
.png)
